Captrust Financial Advisors Bridge Bio Pharma, Inc. Transaction History

Captrust Financial Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $102,637 - $187,541	-4,273 Reduced 14.12%	25,997 $1.05 Million
Q3 2023 Nov 14, 2023	BUY	$16.89 - $35.01 $183,172 - $379,683	10,845 Added 55.83%	30,270 $798,000
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $258,158 - $349,844	19,425 New	19,425 $334,000
Q2 2022 Aug 16, 2022	SELL	$5.21 - $12.14 $521 - $1,214	-100 Reduced 8.82%	1,034 $9,000
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $4,205 - $9,832	573 Added 102.14%	1,134 $12,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $1,297 - $6,088	114 Added 25.5%	561 $9,000
Q3 2021 Nov 16, 2021	BUY	$46.87 - $64.24 $12,561 - $17,216	268 Added 149.72%	447 $21,000
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $1,161 - $1,598	-25 Reduced 12.25%	179 $11,000
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $11,315 - $14,759	204 New	204 $13,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.